<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Ractopamine, a synthetic β(2)-adrenoceptor <z:chebi fb="4" ids="48705">agonist</z:chebi>, is widely used as a feed additive in the United States to promote a reduction in body fat and enhance muscle growth in cattle, pigs, and turkeys </plain></SENT>
<SENT sid="1" pm="."><plain>It has the potential for illegal use in show and racing animals because it may affect performance via its β-<z:chebi fb="0" ids="37886">adrenergic agonist</z:chebi> properties or anabolic activities </plain></SENT>
<SENT sid="2" pm="."><plain>Nine greyhounds were orally administered 1 mg/kg of ractopamine to investigate the ability to detect the drug in urine </plain></SENT>
<SENT sid="3" pm="."><plain>Postdosing, 7 of 9 dogs developed <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo> and had elevated troponin levels indicating myocardial damage </plain></SENT>
<SENT sid="4" pm="."><plain>One dog necropsied 4 days postdosing had massive <z:hpo ids='HP_0001700'>myocardial necrosis</z:hpo>, mild to focally moderate <z:mp ids='MP_0003852'>skeletal muscle necrosis</z:mp>, and widespread segmental arterial mediolysis </plain></SENT>
<SENT sid="5" pm="."><plain>A second dog necropsied 17 days postdosing had mild <z:hpo ids='HP_0001700'>myocardial necrosis</z:hpo> and <z:mp ids='MP_0003045'>fibrosis</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Scattered arteries exhibited segmental medial and perimedial fibromuscular <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>This is the first reported case of arterial, cardiac, and skeletal muscle damage associated with ractopamine </plain></SENT>
</text></document>